CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 161 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q1 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $238,227 | -30.1% | 5,345 | -56.0% | 0.16% | -30.6% |
| Q3 2022 | $341,000 | +65.5% | 12,135 | +59.1% | 0.24% | +59.9% |
| Q2 2022 | $206,000 | -21.1% | 7,625 | -0.7% | 0.15% | -11.4% |
| Q1 2022 | $261,000 | -17.4% | 7,675 | -6.2% | 0.17% | -14.4% |
| Q4 2021 | $316,000 | +6.8% | 8,183 | +49.1% | 0.19% | 0.0% |
| Q3 2021 | $296,000 | +37.7% | 5,489 | -14.4% | 0.19% | +47.0% |
| Q2 2021 | $215,000 | -17.0% | 6,416 | -56.6% | 0.13% | -25.4% |
| Q4 2020 | $259,000 | +38.5% | 14,791 | +17.6% | 0.18% | +17.2% |
| Q3 2020 | $187,000 | – | 12,581 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |